Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for SEELQ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 0.00
September 30, 2023 0.00
June 30, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 -0.003M
September 30, 2018 0.00
June 30, 2018 0.00
Date Value
March 31, 2018 0.00
December 31, 2017 0.234M
September 30, 2017 0.444M
June 30, 2017 1.64M
March 31, 2017 9.996M
December 31, 2016 -0.103M
September 30, 2016 1.448M
June 30, 2016 0.558M
March 31, 2016 -1.206M
December 31, 2015 -0.116M
September 30, 2015 -0.028M
June 30, 2015 -0.023M
March 31, 2015 -0.165M
December 31, 2014 -0.08M
September 30, 2014 -0.049M
June 30, 2014 0.595M
March 31, 2014 -0.305M
December 31, 2013 -0.137M
September 30, 2013 0.212M
June 30, 2013 0.604M
March 31, 2013 4.068M
December 31, 2012
September 30, 2012 1.688M
June 30, 2012 0.002M
March 31, 2012 -0.28M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Filana Therapeutics, Inc. -0.021M
CorMedix, Inc. -0.561M
Eloxx Pharmaceuticals, Inc. 0.00
Cannabis Global, Inc. 0.00
Breakthrough Chemistry, Inc. 0.00